Literature DB >> 18458336

Microdeletions are a general feature of adult and adolescent acute lymphoblastic leukemia: Unexpected similarities with pediatric disease.

Kajsa Paulsson1, Jean-Baptiste Cazier, Finlay Macdougall, Jane Stevens, Irina Stasevich, Nikoletta Vrcelj, Tracy Chaplin, Debra M Lillington, T Andrew Lister, Bryan D Young.   

Abstract

We present here a genome-wide map of abnormalities found in diagnostic samples from 45 adults and adolescents with acute lymphoblastic leukemia (ALL). A 500K SNP array analysis uncovered frequent genetic abnormalities, with cryptic deletions constituting half of the detected changes, implying that microdeletions are a characteristic feature of this malignancy. Importantly, the pattern of deletions resembled that recently reported in pediatric ALL, suggesting that adult, adolescent, and childhood cases may be more similar on the genetic level than previously thought. Thus, 70% of the cases displayed deletion of one or more of the CDKN2A, PAX5, IKZF1, ETV6, RB1, and EBF1 genes. Furthermore, several genes not previously implicated in the pathogenesis of ALL were identified as possible recurrent targets of deletion. In total, the SNP array analysis identified 367 genetic abnormalities not corresponding to known copy number polymorphisms, with all but two cases (96%) displaying at least one cryptic change. The resolution level of this SNP array study is the highest used to date to investigate a malignant hematologic disorder. Our findings provide insights into the leukemogenic process and may be clinically important in adult and adolescent ALL. Most importantly, we report that microdeletions of key genes appear to be a common, characteristic feature of ALL that is shared among different clinical, morphological, and cytogenetic subgroups.

Entities:  

Mesh:

Year:  2008        PMID: 18458336      PMCID: PMC2373322          DOI: 10.1073/pnas.0800408105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

Review 1.  Epidemiology of hematological malignancies.

Authors:  D Rodriguez-Abreu; A Bordoni; E Zucca
Journal:  Ann Oncol       Date:  2007-01       Impact factor: 32.976

2.  Adolescents with acute lymphoblastic leukaemia: emerging from the shadow of paediatric and adult treatment protocols.

Authors:  Ramya Ramanujachar; Sue Richards; Ian Hann; David Webb
Journal:  Pediatr Blood Cancer       Date:  2006-11       Impact factor: 3.167

3.  A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol.

Authors:  Marco Mancini; Daniela Scappaticci; Giuseppe Cimino; Mauro Nanni; Valentina Derme; Loredana Elia; Agostino Tafuri; Marco Vignetti; Antonella Vitale; Antonio Cuneo; Gianluigi Castoldi; Giuseppe Saglio; Fabrizio Pane; Cristina Mecucci; Andrea Camera; Giorgina Specchia; Alessandra Tedeschi; Francesco Di Raimondo; Giuseppe Fioritoni; Francesco Fabbiano; Filippo Marmont; Felicetto Ferrara; Nicola Cascavilla; Giuseppe Todeschini; Francesco Nobile; Maria Grazia Kropp; Pietro Leoni; Antonio Tabilio; Mario Luppi; Luciana Annino; Franco Mandelli; Robin Foà
Journal:  Blood       Date:  2005-01-13       Impact factor: 22.113

4.  The presence of TEL/AML1 rearrangement and cryptic deletion of the TEL gene in adult acute lymphoblastic leukemia (ALL).

Authors:  Dong Soon Lee; Young Ree Kim; Hyung Kyun Cho; Chung Kee Lee; Jee Hyung Lee; Han Ik Cho
Journal:  Cancer Genet Cytogenet       Date:  2005-10-15

5.  Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG).

Authors:  Kirk R Schultz; D Jeanette Pullen; Harland N Sather; Jonathan J Shuster; Meenakshi Devidas; Michael J Borowitz; Andrew J Carroll; Nyla A Heerema; Jeffrey E Rubnitz; Mignon L Loh; Elizabeth A Raetz; Naomi J Winick; Stephen P Hunger; William L Carroll; Paul S Gaynon; Bruce M Camitta
Journal:  Blood       Date:  2006-09-26       Impact factor: 22.113

6.  Genome-wide single nucleotide polymorphism analysis reveals frequent partial uniparental disomy due to somatic recombination in acute myeloid leukemias.

Authors:  Manoj Raghavan; Debra M Lillington; Spyros Skoulakis; Silvana Debernardi; Tracy Chaplin; Nicola J Foot; T Andrew Lister; Bryan D Young
Journal:  Cancer Res       Date:  2005-01-15       Impact factor: 12.701

7.  Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993.

Authors:  Jacob M Rowe; Georgina Buck; Alan K Burnett; Raj Chopra; Peter H Wiernik; Susan M Richards; Hillard M Lazarus; Ian M Franklin; Mark R Litzow; Niculae Ciobanu; H Grant Prentice; Jill Durrant; Martin S Tallman; Anthony H Goldstone
Journal:  Blood       Date:  2005-08-16       Impact factor: 22.113

8.  High-resolution genome-wide array-based comparative genome hybridization reveals cryptic chromosome changes in AML and MDS cases with trisomy 8 as the sole cytogenetic aberration.

Authors:  K Paulsson; M Heidenblad; B Strömbeck; J Staaf; G Jönsson; A Borg; T Fioretos; B Johansson
Journal:  Leukemia       Date:  2006-05       Impact factor: 11.528

9.  Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial.

Authors:  Anthony V Moorman; Christine J Harrison; Georgina A N Buck; Sue M Richards; Lorna M Secker-Walker; Mary Martineau; Gail H Vance; Athena M Cherry; Rodney R Higgins; Adele K Fielding; Letizia Foroni; Elisabeth Paietta; Martin S Tallman; Mark R Litzow; Peter H Wiernik; Jacob M Rowe; Anthony H Goldstone; Gordon W Dewald
Journal:  Blood       Date:  2006-12-14       Impact factor: 22.113

10.  Prognosis of children with acute lymphoblastic leukemia (ALL) and intrachromosomal amplification of chromosome 21 (iAMP21).

Authors:  Anthony V Moorman; Susan M Richards; Hazel M Robinson; Jon C Strefford; Brenda E S Gibson; Sally E Kinsey; Tim O B Eden; Ajay J Vora; Christopher D Mitchell; Christine J Harrison
Journal:  Blood       Date:  2006-11-09       Impact factor: 22.113

View more
  42 in total

Review 1.  Genomic profiling of B-progenitor acute lymphoblastic leukemia.

Authors:  Charles G Mullighan
Journal:  Best Pract Res Clin Haematol       Date:  2011-11-06       Impact factor: 3.020

Review 2.  Beyond the 2008 World Health Organization classification: the role of the hematopathology laboratory in the diagnosis and management of acute lymphoblastic leukemia.

Authors:  Stephanie McGregor; Jennifer McNeer; Sandeep Gurbuxani
Journal:  Semin Diagn Pathol       Date:  2012-02       Impact factor: 3.464

3.  NF1 inactivation in adult acute myelogenous leukemia.

Authors:  Brian Parkin; Peter Ouillette; Yin Wang; Yan Liu; Whitney Wright; Diane Roulston; Anjali Purkayastha; Amanda Dressel; Judith Karp; Paula Bockenstedt; Ammar Al-Zoubi; Moshe Talpaz; Lisa Kujawski; Yang Liu; Kerby Shedden; Sajid Shakhan; Cheng Li; Harry Erba; Sami N Malek
Journal:  Clin Cancer Res       Date:  2010-05-26       Impact factor: 12.531

4.  Acquired genomic copy number aberrations and survival in adult acute myelogenous leukemia.

Authors:  Brian Parkin; Harry Erba; Peter Ouillette; Diane Roulston; Anjali Purkayastha; Judith Karp; Moshe Talpaz; Lisa Kujawski; Sajid Shakhan; Cheng Li; Kerby Shedden; Sami N Malek
Journal:  Blood       Date:  2010-08-20       Impact factor: 22.113

5.  Array-based comparative genomic hybridization detects copy number variations with prognostic relevance in 80% of ALL with normal karyotype or failed chromosome analysis.

Authors:  V Mühlbacher; T Haferlach; W Kern; M Zenger; S Schnittger; C Haferlach
Journal:  Leukemia       Date:  2015-10-09       Impact factor: 11.528

6.  Genetic landscape of high hyperdiploid childhood acute lymphoblastic leukemia.

Authors:  Kajsa Paulsson; Erik Forestier; Henrik Lilljebjörn; Jesper Heldrup; Mikael Behrendtz; Bryan D Young; Bertil Johansson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-22       Impact factor: 11.205

7.  WT1 mutations in T-ALL.

Authors:  Valeria Tosello; Marc R Mansour; Kelly Barnes; Maddalena Paganin; Maria Luisa Sulis; Sarah Jenkinson; Christopher G Allen; Rosemary E Gale; David C Linch; Teresa Palomero; Pedro Real; Vundavalli Murty; Xiaopan Yao; Susan M Richards; Anthony Goldstone; Jacob Rowe; Giuseppe Basso; Peter H Wiernik; Elisabeth Paietta; Rob Pieters; Martin Horstmann; Jules P P Meijerink; Adolfo A Ferrando
Journal:  Blood       Date:  2009-06-03       Impact factor: 22.113

8.  Novel gene targets detected by genomic profiling in a consecutive series of 126 adults with acute lymphoblastic leukemia.

Authors:  Setareh Safavi; Markus Hansson; Karin Karlsson; Andrea Biloglav; Bertil Johansson; Kajsa Paulsson
Journal:  Haematologica       Date:  2014-09-26       Impact factor: 9.941

9.  Advances in the Biology of Acute Lymphoblastic Leukemia-From Genomics to the Clinic.

Authors:  Charles G Mullighan; Cheryl L Willman
Journal:  J Adolesc Young Adult Oncol       Date:  2011-06       Impact factor: 2.223

10.  Association between acquired uniparental disomy and homozygous mutations and HER2/ER/PR status in breast cancer.

Authors:  Musaffe Tuna; Marcel Smid; Dakai Zhu; John W M Martens; Christopher I Amos
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.